Purchase of immunoglobulin for intravenous use (J06BA02)

This tender exhibits significant concerns regarding fairness and data consistency due to contradictory statements about the procurement procedure and evaluation criteria, potentially limiting competition. While basic information is complete and e-procurement is enabled, these critical issues warrant immediate attention.

The statement 'Otstarbekas ost ühelt pakkujalt' (Expedient purchase from one bidder) directly contradicts the likely open procedure type ('A'), raising severe concerns about compliance with competition principles and equal treatment. This ambiguity could lead to legal challenges.

There is a direct contradiction between the 'Evaluation Criteria: relative_weighting' listed in the characteristics and the document summary stating 'total cost (100% weight)' as the sole criterion. This ambiguity is highly problematic for bidders. The 'single bidder' statement also adds to the lack of clarity regarding the procurement's true nature.

The tender provides all essential basic information, including title, reference, organization, financial details, and timelines. All necessary documents, such as technical specifications, evaluation criteria, and a draft contract, are listed and appear to be available.

The 'Otstarbekas ost ühelt pakkujalt' statement is a major red flag, strongly suggesting potential tailoring or an intent to limit competition to a single supplier, which fundamentally undermines the principles of fairness and equal opportunity in public procurement. This is a critical issue.

The tender supports electronic submission and e-procurement, which is practical. Key information like duration and estimated value is provided. However, a direct contract start date is not explicitly stated, and while documents are accessible via the portal, a direct URL to the documents themselves is not provided in the basic info.

Multiple inconsistencies are present: the evaluation criteria are contradictory ('relative_weighting' vs. 'total cost 100%'), and the 'Value Classified: Yes' conflicts with the disclosed estimated value. Most critically, the 'Procedure: A' (likely open) is inconsistent with the 'single bidder' statement.

The tender does not include any specific criteria or mentions related to green procurement, social aspects, or innovation. It is also not indicated as EU-funded, which often correlates with higher sustainability standards.